What is the recommended MRI protocol for diagnosing and monitoring multiple sclerosis?

MRI Protocol for Multiple Sclerosis Diagnosis and Monitoring

For initial diagnosis of MS, obtain brain and whole spinal cord MRI with gadolinium contrast at 1.5T or 3T, using 3D T2-FLAIR, T2-weighted sequences, susceptibility-sensitive imaging for central vein sign detection, and post-contrast T1-weighted sequences. 1

Initial Diagnostic MRI Protocol

Scanner Requirements and Technical Specifications

• Field strength: Minimum 1.5T or 3T 1, 2
• Spatial resolution: Maximum 1 × 1 mm in-plane pixel size 1
• Slice thickness:
  • 3D acquisitions with isotropic voxels ≤1 mm (preferred) 1
  • If using older scanners: contiguous 2D slices with maximum 3 mm thickness 1
• Slice positioning: Consistent axial alignment along subcallosal line or anterior-posterior commissure for reliable follow-up comparisons 1

Core Brain Sequences

The following sequences must be acquired 1:

1. 3D T2-FLAIR (primary lesion detection sequence)

   • Preferably 3D acquisition for multiplanar reconstruction 1
   • Alternative: 2D T2-FLAIR with 3 mm slices 2

2. T2-weighted sequences (single or dual echo)

   • Confirms posterior fossa lesions 1
   • Alternative: Proton density-weighted 2

3. Susceptibility-sensitive sequences (now recommended for routine use)

   • For central vein sign (CVS) identification 1
   • 3D segmented echo-planar imaging with maximum 1.0 mm isotropic resolution 1
   • Can use FLAIR* (voxel-wise multiplication of 3D segmented EPI and T2-FLAIR) to simplify CVS reading 1
   • Phase images should be saved for paramagnetic rim lesion (PRL) identification 1

4. Post-contrast T1-weighted sequences

   • Timing: Minimum 5-minute delay after gadolinium injection 1
   • Use this delay to acquire FLAIR and susceptibility sequences 1
   • Pre-contrast T1 is NOT routinely needed (MS lesions are rarely spontaneously T1-hyperintense) 1

Gadolinium Administration for Initial Diagnosis

• Required for initial diagnostic scan to detect enhancing lesions and evaluate differential diagnoses 1
• Standard dose: 0.1 mmol/kg bodyweight 1
• Strongly prefer macrocyclic gadolinium agents due to lower risk of gadolinium deposition and reduced need for renal function monitoring 1
• Safe during breastfeeding but avoid in pregnancy unless clinically essential 1
• Allows fulfillment of dissemination in time (DIT) criteria when both enhancing and non-enhancing lesions are present 1

Spinal Cord Imaging

• Image the entire spinal cord (cervical, thoracic, and lumbar) at initial diagnosis 1, 2
• Purpose: Demonstrate DIT, exclude differential diagnoses, inform prognosis, establish baseline 1
• Key sequences 2:
  • Sagittal T2-weighted
  • Sagittal STIR (short-tau inversion recovery)
  • Post-contrast T1-weighted (at initial diagnosis only)

Optic Nerve Imaging (When Indicated)

• Fat-suppressed sequences 2
• Consider especially in atypical cases to rule out alternative diagnoses 2
• Now incorporated as fifth topography for dissemination in space in 2024 McDonald criteria 3

Follow-Up MRI Protocol

For Establishing Dissemination in Time

• Gadolinium is NOT required for repeat brain imaging 1
• New T2-FLAIR lesions alone suffice to demonstrate DIT 1
• Repeat spinal cord imaging is NOT routinely recommended (isolated new spinal cord lesions without brain lesions are rare) 1

For Disease Monitoring

• Use same 3D T2-FLAIR protocol as baseline for optimal lesion detection 1
• Consistent repositioning and image registration are essential 1
• 3D acquisitions with isotropic voxels allow good realignment with previous scans 1

Diagnostic Criteria Application

Lesion Location Requirements

At least one typical MS lesion in at least two of these regions 2:

• Periventricular (abutting the lateral ventricles)
• Juxtacortical
• Infratentorial
• Spinal cord (cervical + thoracic)
• Optic nerve (per 2024 criteria) 3

Key Diagnostic Features

• Central vein sign: High proportion of lesions with CVS increases diagnostic specificity 1
• Paramagnetic rim lesions: Presence of ≥4 PRLs associated with greater disability and poor prognosis 1
• Gadolinium enhancement: Typically transient (2-8 weeks, usually 4 weeks) 2

Critical Caveats

Age-Related Considerations

• Patients >50 years or with vascular risk factors: Apply more stringent criteria (require higher number of periventricular lesions abutting lateral ventricles) 2
• Pediatric patients <11 years: Special care needed; presence of at least one T1-hypointense "black hole" and one periventricular lesion helps distinguish MS from monophasic demyelination 2

Quality Control

• Scans must be adequate quality with minimal artifacts 2
• Confirm lesions on multiple planes to avoid false positives from artifacts 2
• Interpretation should be by trained neuroradiologists or clinicians deeply familiar with MS features 2

Prognostic Value of Initial MRI

The initial MRI provides critical prognostic information 1:

• Spinal cord lesions: Strong predictor of long-term disability accrual 1
• Brainstem lesions: Strongly predict long-term disability 1
• ≥4 paramagnetic rim lesions: Associated with greater disability 1
• T1-hypointense lesions: Portend poor prognosis 1
• Early brain volume loss: Associated with long-term disability accumulation 1

Structured Reporting Recommendations

Radiology reports should include 1:

• Lesion number, location, size, and morphology
• Universal nomenclature (periventricular vs. deep white matter, not "subcortical")
• Whether findings fulfill radiological aspects of diagnostic criteria
• Recommendations for follow-up imaging to establish DIT if needed
• Assessment of CVS and PRL presence when susceptibility imaging performed